Effects of some cholinergic, adrenergic and serotoninergic compounds, glutamic acid and GABA on hippocampal seizures.
D000109:Acetylcholine / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D005971:Glutamates / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010477:Perfusion; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000139:chemically induced*; D012701:Serotonin / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000494:pharmacology*
D000613:Aminobutyrates; D005971:Glutamates; D006584:Hexamethonium Compounds; D008781:Methyltyrosines; D010277:Parasympathomimetics; D013566:Sympathomimetics; D012701:Serotonin; D003983:Dibenzylchlorethamine; D001285:Atropine; D010830:Physostigmine; D000109:Acetylcholine; D010134:Fenclonine; D009638:Norepinephrine; D008784:Methysergide